Robert Hilgraf

As Vice President of Molecular Design, Robert is responsible for leading the medicinal chemistry efforts at insitro by integrating machine-learning into the medicinal chemistry and drug discovery process. He is utilizing the company’s platform to move drug discovery programs towards the clinic.